Prothena reported $-50332000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Agios Pharmaceuticals AGIO:US USD -86647000 8.29M
Akebia Therapeutics AKBA:US USD -49080000 82.98M
ALKERMES ALKS:US USD -60641000 26.18M
Alnylam Pharmaceuticals ALNY:US USD -334626000 142.94M
Amgen AMGN:US USD 2.74B 562M
Biogen BIIB:US USD 1.32B 1.37B
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bluebird Bio BLUE:US USD -84781000 22.62M
Exelixis EXEL:US USD 82.61M 1.09M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
Intra Cellular Therapies ITCI:US USD -55629000 32.29M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
Macrogenics MGNX:US USD -24955000 16.85M
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Prothena PRTA:US USD -50332000 7.12M
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Seattle Genetics SGEN:US USD -192805000 59.69M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Vertex Pharmaceuticals VRTX:US USD 1.13B 20.4M
Vital Therapies VTL:US USD -20116000 494K
Xoma XOMA:US USD -4372000 395K
YTE INCY:US USD 138.38M 116.06M